Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Inserm · New Leaders · +41 more institutions
Abstract
The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a "treat-to-target" clinical management strategy using an evidence-based expert consensus process.
A Steering Committee of 28 IBD specialists developed recommendations based on a systematic literature review and expert opinion. Consensus was gained if ≥75% of participants scored the recommendation as 7-10 on a 10-point rating scale (where 10=agree completely).
Citation impact
- FWCI
- 90.53
- Percentile
- 100%
- References
- 188
Authors
38- LPLaurent Peyrin‐Biroulet
Inserm, New Leaders, Open Targets, Kleijnen Systematic Reviews (United Kingdom), Sands, Université de Lorraine
- WJWilliam J. Sandborn
New Leaders, University of California San Diego, Open Targets, Kleijnen Systematic Reviews (United Kingdom), Sands
- BEBruce E. Sands
New Leaders, Open Targets, Kleijnen Systematic Reviews (United Kingdom), Sands, Icahn School of Medicine at Mount Sinai
- WRWalter Reinisch
Medical University of Vienna, McMaster University
- WAWillem A. Bemelman
New Leaders, Amsterdam UMC Location University of Amsterdam, Open Targets, Kleijnen Systematic Reviews (United Kingdom), Sands
Topics & keywords
- Medicine
- Inflammatory bowel disease
- STRIDE
- Intensive care medicine
- Disease
- Therapeutic approach
- Physical medicine and rehabilitation
- Internal medicine